MKI67 and neoplasm: Utilizing this gene set, we evaluated all tumor cell subpopulations and discovered that C2 MKI67+ TCs—predominantly in the G2/M and S phases—demonstrated significantly heightened heart failure scores, whereas their cardiac fibrosis scores were not substantially elevated.